Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from InhaleRx Limited ( (AU:IRX) ).
InhaleRx Limited announced a proposed issue of securities, including 15 million unlisted options and 30 million ordinary fully paid shares, set to be issued on November 28, 2025. This strategic move is expected to bolster the company’s financial position, potentially enhancing its market presence and providing additional capital for future growth initiatives.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and distribution of inhalation-based drug delivery systems. The company aims to enhance therapeutic outcomes through innovative inhalation technologies, targeting various medical conditions.
Average Trading Volume: 257,297
Technical Sentiment Signal: Hold
Current Market Cap: A$7.85M
Learn more about IRX stock on TipRanks’ Stock Analysis page.